Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children

BACKGROUND: Parainfluenza virus (PIV), a common pediatric pathogen, is associated with significant morbidity in immunocompromised (IC) hosts. DAS181, a novel sialidase fusion protein inhibitor, seems to be effective against PIV in vitro and in vivo; its use in IC children has not been evaluated. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Waghmare, Alpana, Wagner, Thor, Andrews, Robert, Smith, Sherilyn, Kuypers, Jane, Boeckh, Michael, Moss, Ronald, Englund, Janet A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501511/
https://www.ncbi.nlm.nih.gov/pubmed/26185620
http://dx.doi.org/10.1093/jpids/piu039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501511/
https://www.ncbi.nlm.nih.gov/pubmed/26185620
http://dx.doi.org/10.1093/jpids/piu039

Ejemplares similares